This report describes the global market size of Weight Loss Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.
For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
For the competitor segment, the report includes global key players of Weight Loss Drug as well as some small players.
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Weight Loss Drug as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Types Segment
- Semaglutide
- Liraglutide
- Phentermine
- Phentermine-topiramate
- Naltrexone-bupropion
- Setmelanotide
- Orlistat
- Hydrogel
- Others
Companies Covered
- NovoNordisk
- Eli Lilly
- Roche Holding AG
- GlaxoSmithKline plc
- Arena Pharmaceuticals
- VIVUS
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
Chapter 4 Market Landscape
Chapter 5 Market Trend Analysis
Chapter 6 Industry Chain Analysis
Chapter 7 Latest Market Dynamics
Chapter 8 Historical and Forecast Weight Loss Drug Market in North America (2019-2029)
Chapter 9 Historical and Forecast Weight Loss Drug Market in South America (2019-2029)
Chapter 10 Historical and Forecast Weight Loss Drug Market in Asia & Pacific (2019-2029)
Chapter 11 Historical and Forecast Weight Loss Drug Market in Europe (2019-2029)
Chapter 12 Historical and Forecast Weight Loss Drug Market in MEA (2019-2029)
Chapter 13 Summary For Global Weight Loss Drug Market (2019-2024)
Chapter 14 Global Weight Loss Drug Market Forecast (2024-2029)
Chapter 15 Analysis of Global Key Vendors
List of Tables and Figures
Companies Mentioned
- NovoNordisk
- Eli Lilly
- Roche Holding AG
- GlaxoSmithKline plc
- Arena Pharmaceuticals
- VIVUS
- Orexigen Therapeutics
- Gelesis Holdings Inc.
Methodology
LOADING...